• Suitable treatment against acute leptospirosis, before renal symptoms appear.
  • Affinity for renal tissue: more than half of the streptomycin is excreted in the urine.
  • Occupational safety problems: It is a zoonotic disease.
  • Counteracts the harmful effects of leptospirosis: low pregnancy rates, high discard rates due to low fertility and abortions.
  • Prevents the increase of work caused by this disease.
  • Simultaneous treatment with vaccination in infected flocks/herds.
COMPOSITION PER ML
Dihidroestreptomicina (sulfato) 250 mg.
DOSAGE AND ADMINISTRATION METHODS
1 ml/10 kg l.w. per day, for 3-4 days IM route.
The weight of the animals must be determined with the greatest possible precision to avoid insufficient dosing.
Do not administer more than 10 ml in calves per injection site.
Provide for sufficient separation between the points of injection when several places of administration are necessary.
Make sure to keep a minimum distance of 15 cm between all injections administered as part of the treatment.
product form
  • Solution for injection
Trust innovation

Continued growth and improvement

At draxpharma, we understand that consistent growth is only achieved with a firm commitment to evolution and improvement. Ideas and suggestions for new partnerships, new products and new technologies are always welcome.

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .

Africa

Asia

Europe

North America

Oceania

South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.

Europe

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now